Why the study?
Does clinical pharmacist participation in the ICU improve clinical and economic outcomes in critically ill Medicare patients with thromboembolic or infarction-related events?
Population
141,079 critically ill Medicare patients with thromboembolic or infarction-related events, of whom 7,987 had…
Comparison
Clinical pharmacy services. vs ICUs without clinical pharmacy services.
Design
Cohort
Follow-up
Duration of ICU stay
Authors
Loading...
May support pharmacist integration in ICU thromboembolic care; observational design leaves causal benefit open for RCTs.
Does clinical pharmacist participation in the ICU improve clinical and economic outcomes in critically ill Medicare patients with thromboembolic or infarction-related events?
Involving clinical pharmacists in the direct care of ICU patients with thromboembolic or infarction-related events is associated with reduced mortality, improved clinical and economic outcomes, and fewer bleeding complications.
MacLaren et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: